Dr. Daniel Hunter Katz, MD

Dr. Katz practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Katz's NPI, 1336552405, was assigned on June 6, 2014. Dr. Katz graduated from Feinberg School of Medicine in 2014. Dr. Katz holds California license A170867.

Dr. Katz's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Katz's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Katz is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Katz to 1 more hospital and 1 medical group, each named with a free account. Dr. Katz's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katz practices, 3 sites in all. Vendor and product names are available with a free account.

Advanced heart failure and transplant cardiology is Dr. Katz's primary specialty in the NPI Registry, under taxonomy code 207RA0001X. Dr. Katz is board certified in advanced heart failure and transplant cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Katz's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, circulation problems, congestive heart failure, coronary artery disease, heart attack and heart failure among the conditions Dr. Katz treats.

CMS data shows 698 Medicare services from Dr. Katz across 9 procedure codes in 2024, for 491 Medicare patients. Medicare paid $35,275 for them.

CMS counts 491 Medicare patients who saw Dr. Katz in 2024. The largest group is 75 to 84, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katz's median patient age at 60, with 38% women.

In 2024, Dr. Katz wrote 532 Medicare Part D claims for 74 patients. 84% of them were for generic drugs. CMS names the drug for 415 of them, across 20 drugs with 11 or more claims each, at $83,878 in total drug cost. In 2023, CMS named 291 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Katz for performance year 2024, reported as part of a group. Dr. Katz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Katz as offering telehealth.

Dmand AI links 42 papers to Dr. Katz, published from 2013 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Heart Failure, Stroke Volume and Proteomics. Dr. Katz has published most often in Am J Cardiol. Dr. Katz's most frequent co-authors are Usman Ahmad Tahir, MD, Jeremy Michael Robbins, MD and Thomas Jue-Fuu Wang, MD.

CMS Open Payments shows 5 general payments to Dr. Katz from 1 drug or device company from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. CVRx, Inc. paid the most, $169.

Dr. Katz graduated from Feinberg School of Medicine in 2014.

Dr. Katz is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.